BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 24915018)

  • 1. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye.
    Li Y; Cui L; Lee HS; Kang YS; Choi W; Yoon KC
    Curr Eye Res; 2017 Aug; 42(8):1108-1114. PubMed ID: 28441078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
    Park DH; Chung JK; Seo DR; Lee SJ
    Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
    Jee D; Park M; Lee HJ; Kim MS; Kim EC
    J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
    Byun YJ; Kim TI; Kwon SM; Seo KY; Kim SW; Kim EK; Park WC
    Cornea; 2012 May; 31(5):509-13. PubMed ID: 19730097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
    Park Y; Song JS; Choi CY; Yoon KC; Lee HK; Kim HS
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
    Mencucci R; Boccalini C; Caputo R; Favuzza E
    J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.
    Liew SH; Nichols KK; Klamerus KJ; Li JZ; Zhang M; Foulks GN
    Ophthalmology; 2012 Jul; 119(7):1328-35. PubMed ID: 22525048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
    Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
    Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
    He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
    Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Enhances the Efficacy of Topical Artificial Tears in Patients With Dry Eye Disease.
    Hwang JS; Lee YP; Shin YJ
    Cornea; 2019 Mar; 38(3):304-310. PubMed ID: 30531497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye.
    Oh HJ; Li Z; Park SH; Yoon KC
    J Ocul Pharmacol Ther; 2014 Sep; 30(7):533-42. PubMed ID: 24766323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
    Johnson ME; Murphy PJ; Boulton M
    Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium hyaluronate on wavefront aberrations in dry eye patients.
    Lekhanont K; Chuckpaiwong V; Vongthongsri A; Sangiampornpanit T
    Optom Vis Sci; 2014 Jan; 91(1):39-46. PubMed ID: 24366433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients.
    Papa V; Aragona P; Russo S; Di Bella A; Russo P; Milazzo G
    Ophthalmologica; 2001; 215(2):124-7. PubMed ID: 11244343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.